Trifluoroacetic acid → HCID 86679139, compound
Reaction equation
C(OC([N:8]1[CH2:11][C:10]2([CH2:14][N:13]([C:15]3[CH:20]=[N:19][CH:18]=[C:17]([C:21]4[CH:22]=[C:23]5[C:28](=[CH:29][CH:30]=4)[N:27]([CH3:31])[C:26](=[O:32])[CH2:25][CH2:24]5)[N:16]=3)[CH2:12]2)[CH2:9]1)=O)(C)(C)C.[C:33]([OH:39])([C:35]([F:38])([F:37])[F:36])=[O:34]>C(Cl)Cl>[F:36][C:35]([F:38])([F:37])[C:33]([OH:39])=[O:34].[CH2:12]1[C:10]2([CH2:9][NH:8][CH2:11]2)[CH2:14][N:13]1[C:15]1[N:16]=[C:17]([C:21]2[CH:22]=[C:23]3[C:28](=[CH:29][CH:30]=2)[N:27]([CH3:31])[C:26](=[O:32])[CH2:25][CH2:24]3)[CH:18]=[N:19][CH:20]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 6-[6-(1-methyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrazin-2-yl]-2,6-diaza-spiro[3.3]heptane-2-carboxylic acid tert-butyl ester (example 28, 0.231 g, 0.53 mmol) in DCM (3 mL) was added TFA (0.605 g, 5.3 mmol) and the reaction mixture was stirred at room temperature over night. The mixture was evaporated several times with toluene and then the residue was purified by reverse phase HPLC on a Gemini-NX column, eluting with a 20 to 98% MeOH—H2O (0.05% TEA) gradient to give the title compound (0.203 g, 99%) as a yellow solid (TFA salt). MS: 336.3 (M+H+).
Workup
- customThe mixture was evaporated several times with toluene
- customthe residue was purified by reverse phase HPLC on a Gemini-NX column
- washeluting with a 20 to 98% MeOH—H2O (0.05% TEA) gradient
Sources & evidence
- ORD record
- ord-d8e36c73324c4698a14690415d8a9c27
- Source dataset
- uspto-grants-2016_02
- Patent number
- US09260408B2
Reaction notes
Loading…